Your browser is no longer supported. Please, upgrade your browser.
Settings
TXMD TherapeuticsMD, Inc. daily Stock Chart
TXMD [NASD]
TherapeuticsMD, Inc.
Index- P/E- EPS (ttm)-0.52 Insider Own8.40% Shs Outstand231.88M Perf Week-0.78%
Market Cap1.18B Forward P/E- EPS next Y-0.57 Insider Trans-20.57% Shs Float195.20M Perf Month41.55%
Income-114.70M PEG- EPS next Q-0.17 Inst Own74.20% Short Float35.94% Perf Quarter-12.05%
Sales15.10M P/S78.47 EPS this Y18.30% Inst Trans-0.03% Short Ratio20.99 Perf Half Y-23.85%
Book/sh0.59 P/B8.66 EPS next Y3.40% ROA-68.00% Target Price16.00 Perf Year-17.18%
Cash/sh0.82 P/C6.24 EPS next 5Y15.00% ROE-102.10% 52W Range3.51 - 7.66 Perf YTD34.12%
Dividend- P/FCF- EPS past 5Y0.50% ROI-59.80% 52W High-33.29% Beta1.90
Dividend %- Quick Ratio7.10 Sales past 5Y34.50% Gross Margin84.30% 52W Low45.79% ATR0.28
Employees173 Current Ratio7.20 Sales Q/Q-20.50% Oper. Margin- RSI (14)63.58 Volatility4.37% 7.08%
OptionableYes Debt/Eq0.55 EPS Q/Q-121.30% Profit Margin- Rel Volume0.64 Prev Close5.24
ShortableYes LT Debt/Eq0.55 EarningsFeb 06 AMC Payout- Avg Volume3.34M Price5.11
Recom- SMA2018.04% SMA5012.91% SMA200-9.64% Volume2,143,111 Change-2.48%
Jun-15-18Initiated JP Morgan Overweight $11
Sep-08-17Initiated Morgan Stanley Equal-Weight $6
Jul-11-17Upgrade Oppenheimer Perform → Outperform
May-09-17Downgrade Oppenheimer Outperform → Perform
Nov-22-16Resumed Jefferies Buy $18
Nov-22-16Initiated Oppenheimer Outperform
Nov-07-16Resumed Guggenheim Buy
Apr-04-16Initiated Goldman Buy $10
Dec-08-15Reiterated Stifel Buy $10 → $14
Dec-08-15Reiterated Jefferies Buy $15 → $18
Sep-21-15Reiterated Jefferies Buy $7 → $15
Jun-09-15Initiated Guggenheim Buy
Jul-08-14Initiated FBR Capital Outperform $34
Apr-17-14Reiterated Noble Financial Buy $9 → $13
Jan-28-14Reiterated Noble Financial Buy $7.25 → $9
Nov-01-13Initiated Stifel Buy $8
Jan-17-19 08:51AM  Implied Volatility Surging for TherapeuticsMD (TXMD) Stock Options Zacks
Jan-10-19 03:17PM  Why TherapeuticsMD's Stock Spiked Today Motley Fool +12.56%
Jan-03-19 07:00AM  TherapeuticsMD Announces Participation at 37th Annual J.P. Morgan Healthcare Conference Business Wire
Dec-21-18 12:40PM  The Charts of TherapeuticsMD Look Bearish to Me TheStreet.com
07:18AM  Jim Cramer Weighs In On Palo Alto, Blackstone And More Benzinga
Dec-20-18 06:54PM  Cramer's lightning round: These cybersecurity stocks are the ones to own in this market CNBC -7.05%
11:19AM  Is TherapeuticsMD Inc (TXMD) A Good Stock To Buy? Insider Monkey
Dec-03-18 08:00AM  Detailed Research: Economic Perspectives on TESARO, Regeneron Pharmaceuticals, Pool, Zebra Technologies, Cadence Design, and TherapeuticsMD What Drives Growth in Today's Competitive Landscape GlobeNewswire
Nov-19-18 01:00PM  Fast-growing pharmaceutical company signs $20M lease to expand Boca Raton HQ American City Business Journals
Nov-12-18 04:30PM  TherapeuticsMD Announces Participation in Three Upcoming Investor Conferences Business Wire
Nov-08-18 03:53AM  Edited Transcript of TXMD earnings conference call or presentation 7-Nov-18 9:30pm GMT Thomson Reuters StreetEvents +6.42%
Nov-07-18 06:12PM  TherapeuticsMD: 3Q Earnings Snapshot Associated Press
04:05PM  TherapeuticsMD Announces Third Quarter 2018 Financial Results Business Wire
Nov-06-18 01:12PM  TherapeuticsMD Incs (NASDAQ:TXMD) Profit Outlook Simply Wall St.
Oct-30-18 07:00AM  TherapeuticsMD to Report Third Quarter 2018 Financial Results on November 7, 2018 Business Wire
Oct-29-18 03:04PM  Why TherapeuticsMD Is Sinking Despite Sharing Good News Motley Fool -6.48%
10:31AM  TherapeuticsMD (TXMD) Q3 Earnings Preview: What to Watch Ahead of the Release Zacks
08:00AM  Today's Research Reports on Trending Tickers: TherapeuticsMD and Horizon Pharma Public ACCESSWIRE
06:27AM  U.S. FDA approves TherapeuticsMD's menopause drug Reuters
06:00AM  TherapeuticsMD Announces FDA Approval of TX-001HR: BIJUVA (Estradiol and Progesterone) Capsules for the Treatment of Moderate to Severe Vasomotor Symptoms Due to Menopause Business Wire
Oct-24-18 08:25AM  Consolidated Research: 2018 Summary Expectations for Novavax, Caesars Entertainment, SeaWorld Entertainment, LendingTree, CVS Health, and TherapeuticsMD Fundamental Analysis, Key Performance Indications GlobeNewswire
Oct-16-18 06:33AM  3 Biotechs Awaiting FDA Approval Decisions Motley Fool +7.57%
Oct-11-18 10:30AM  Cannabis and Biotech Stocks That Have Run Parabolically ACCESSWIRE
Sep-28-18 08:32AM  Today's Research Reports on Trending Tickers: TherapeuticsMD and Endo International ACCESSWIRE
07:00AM  TherapeuticsMD Announces Multiple Presentations Related to Imvexxy and TX-001HR at the 2018 Annual Meeting of the North American Menopause Society Business Wire
Sep-27-18 04:05PM  TherapeuticsMD Enters Into Label Discussions for TX-001HR Business Wire
Sep-26-18 08:30AM  Implied Volatility Surging for TherapeuticsMD (TXMD) Stock Options Zacks
Sep-25-18 07:00AM  TherapeuticsMD to Present at 2018 Cantor Global Healthcare Conference Business Wire
Sep-20-18 07:00AM  TherapeuticsMD Announces the FDA has Granted AnnoveraTM Marketing Exclusivity as a New Chemical Entity Business Wire +8.52%
Sep-13-18 07:00AM  TherapeuticsMD Announces Commercial Availability of Imvexxy 4 mcg Business Wire
Sep-12-18 12:56PM  What You Must Know About TherapeuticsMD Incs (NASDAQ:TXMD) Market Risks Simply Wall St.
Sep-11-18 10:30AM  High Value Cannabis and Biotech Stocks ACCESSWIRE
Sep-10-18 12:22PM  Here's Why TherapeuticsMD Jumped 24.1% in August Motley Fool
Aug-22-18 07:00AM  TherapeuticsMD to Present at 13th Annual Wells Fargo Securities Healthcare Conference Business Wire
Aug-17-18 12:48PM  Edited Transcript of TXMD earnings conference call or presentation 30-Jul-18 12:30pm GMT Thomson Reuters StreetEvents
Aug-15-18 08:25PM  Key FDA Decisions Could Power These 3 Biopharma Stocks SmarterAnalyst
Aug-10-18 04:09PM  FDA Approves New Form Of Self-Administered Female Birth Control Benzinga
03:05PM  TherapeuticsMD Announces FDA Approval of ANNOVERA (Segesterone Acetate/Ethinyl Estradiol Vaginal System) for Birth Control Business Wire
Aug-09-18 05:48AM  TherapeuticsMD Receives Bullish Note From Street on New Found Potential Investopedia
Aug-06-18 04:05PM  TherapeuticsMD Announces Closing of its Underwritten Public Offering and Concurrent Registered Direct Offering of Common Stock Business Wire
Aug-01-18 09:36PM  TherapeuticsMD Announces Pricing of Its Underwritten Public Offering and Concurrent Registered Direct Offering for Aggregate Gross Proceeds of $85 Million Business Wire
Jul-31-18 04:15PM  TherapeuticsMD Licenses Population Councils Novel Segesterone Acetate/ Ethinyl Estradiol One-Year Vaginal Contraceptive System Business Wire -5.43%
04:13PM  Knight Therapeutics and TherapeuticsMD Announce Strategic Partnership Business Wire
04:09PM  TherapeuticsMD Announces Proposed $65 Million Underwritten Public Offering and Concurrent $20 Million Registered Direct Offering of Common Stock Business Wire
Jul-30-18 06:30AM  TherapeuticsMD, Inc. to Host Earnings Call ACCESSWIRE -9.21%
06:15AM  TherapeuticsMD Announces Second Quarter 2018 Financial Results Business Wire
Jul-25-18 07:00AM  TherapeuticsMD to Report Second Quarter 2018 Financial Results on July 30, 2018 Business Wire
Jul-17-18 07:30AM  Free Pre-Market Technical Recap on TherapeuticsMD and Three Additional Healthcare Stocks ACCESSWIRE
Jun-07-18 04:05PM  TherapeuticsMD Announces Draw Down of $75 Million Under Term Loan with MidCap Financial Business Wire
08:34AM  TherapeuticsMD (TXMD) Soars: Stock Adds 9.1% in Session Zacks
07:00AM  TherapeuticsMD to Present at Goldman Sachs 39th Annual Global Healthcare Conference Business Wire
Jun-06-18 07:30AM  Stock Performance Review on TherapeuticsMD and Three Other Healthcare Stocks ACCESSWIRE +9.10%
07:00AM  TherapeuticsMD Announces Multiple Presentations at the International Menopause Societys 16th World Congress Business Wire
Jun-05-18 04:04PM  Here's Why TherapeuticsMD Inc Jumped Today Motley Fool +13.23%
Jun-04-18 04:30PM  TherapeuticsMD to Present at Jefferies 2018 Healthcare Conference Business Wire
08:30AM  Today's Research Reports on Trending Tickers: AbbVie and TherapeuticsMD ACCESSWIRE
May-31-18 04:10PM  TherapeuticsMD Announces Clinical Abstract at the 2018 ASCO Annual Meeting Business Wire
02:26PM  What Scpharmaceuticals (SCPH) Investors Can Learn from the History SmarterAnalyst
May-30-18 10:54AM  TherapeuticsMD's therapy for menopause-related condition gets approval Reuters -5.75%
09:37AM  TherapeuticsMD Announces FDA Approval of TX-004HR: IMVEXXY (estradiol vaginal inserts), the Lowest Dose Vaginal Estrogen Product Approved for the Treatment of Moderate to Severe Dyspareunia, a Symptom of VVA, due to Menopause PR Newswire
09:34AM  TherapeuticsMD Announces FDA Approval Of IMVEXXY For Real This Time Benzinga
06:00AM  TherapeuticsMD Announces FDA Approval of TX-004HR: IMVEXXY (estradiol vaginal inserts), the Lowest Dose Vaginal Estrogen Product Approved for the Treatment of Moderate to Severe Dyspareunia, a Symptom of VVA, Due to Menopause Business Wire
May-29-18 08:30AM  Today's Research Reports on Trending Tickers: Tesaro and TherapeuticsMD ACCESSWIRE
May-23-18 12:38PM  TherapeuticsMD Comments on Media Reports Regarding TX-004HR Business Wire
May-21-18 08:43AM  Options Traders Expect Huge Moves in TherapeuticsMD (TXMD) Stock Zacks
May-16-18 04:30PM  TherapeuticsMD Announces Investor and Analyst Day on June 4 Business Wire
May-15-18 05:52PM  Edited Transcript of TXMD earnings conference call or presentation 3-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-03-18 06:20PM  TherapeuticsMD: 1Q Earnings Snapshot Associated Press
04:05PM  TherapeuticsMD Announces First Quarter 2018 Financial Results Business Wire
May-01-18 04:30PM  TherapeuticsMD to Host First Quarter Financial Results Conference Call and Webcast on May 3 Business Wire
Apr-11-18 06:00AM  TherapeuticsMD Enters Into Label Negotiations for TX-004HR Business Wire +9.67%
Apr-02-18 07:00AM  TherapeuticsMD Announces Expansion of Board of Directors Business Wire
Mar-19-18 08:10AM  TherapeuticsMD, New PipelineNDA Development, Analysts Target and PDUFA Date ACCESSWIRE
Mar-09-18 08:10AM  Todays Research Reports on Stocks to Watch: AcelRx Pharmaceuticals and TherapeuticsMD ACCESSWIRE
Mar-08-18 04:15PM  TherapeuticsMD Announces FDA Acceptance of New Drug Application (NDA) and Prescription Drug User Fee Act (PDUFA) Date for TX-001HR Business Wire
Mar-06-18 04:30PM  TherapeuticsMD to Present at Two Upcoming Investor Conferences Business Wire
Feb-23-18 05:49PM  TherapeuticsMD Inc (TXMD) Files 10-K for the Fiscal Year Ended on December 31, 2017 GuruFocus.com +7.19%
07:20AM  Wired News - Merck to Acquire Australia-based Viralytics to Broaden Immuno-Oncology Portfolio ACCESSWIRE
Feb-21-18 10:01AM  Edited Transcript of TXMD earnings conference call or presentation 20-Feb-18 9:30pm GMT Thomson Reuters StreetEvents
Feb-20-18 05:29PM  TherapeuticsMD reports 4Q loss Associated Press
04:05PM  TherapeuticsMD Announces Fourth Quarter and Full Year 2017 Financial Results Business Wire
12:09PM  TherapeuticsMD Q4 Earnings Preview Benzinga
12:00PM  TherapeuticsMD, Inc. to Host Earnings Call ACCESSWIRE
Feb-15-18 07:45AM  Research Report Identifies Louisiana-Pacific, Vmware, ZAGG, FS Investment, TherapeuticsMD, and Kennedy-Wilson with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Feb-06-18 04:30PM  TherapeuticsMD to Host Fourth Quarter and Year End 2017 Financial Results Conference Call and Webcast on February 20 Business Wire +5.14%
Jan-09-18 08:08AM  See what the IHS Markit Score report has to say about TherapeuticsMD Inc. Markit
Jan-03-18 04:30PM  TherapeuticsMD Announces Presentation at 36th Annual J.P. Morgan Healthcare Conference on January 10 Business Wire
Jan-02-18 08:08AM  See what the IHS Markit Score report has to say about TherapeuticsMD Inc. Markit
Dec-29-17 09:55AM  TherapeuticsMD Submits NDA for VMS Candidate, Shares Rise Zacks
Dec-28-17 04:30PM  TherapeuticsMD Announces Submission of New Drug Application for TX-001HR Business Wire
Dec-26-17 12:16PM  ETFs with exposure to TherapeuticsMD, Inc. : December 26, 2017 Capital Cube
Dec-25-17 09:37AM  TherapeuticsMD, Inc. :TXMD-US: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017 Capital Cube
Dec-20-17 10:11AM  TherapeuticsMD Falls Despite Acceptance of NDA: Here's Why Zacks
09:05AM  TherapeuticsMD shares drop 7% on new FDA review timeline for its drug MarketWatch
Dec-19-17 04:36PM  TherapeuticsMD Announces FDA Acceptance of New Drug Application and Prescription Drug User Fee Act (PDUFA) Date for TX-004HR Business Wire -6.37%
Dec-08-17 08:07AM  See what the IHS Markit Score report has to say about TherapeuticsMD Inc. Markit
Dec-01-17 07:30AM  Recent Analysis Shows FS Investment, TherapeuticsMD, Kennedy-Wilson, Louisiana-Pacific, Vmware, and ZAGG Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Nov-30-17 09:42AM  Cantor Bets TherapeuticsMD Bears Could Be Getting Desperate; Heres Why SmarterAnalyst
08:08AM  See what the IHS Markit Score report has to say about TherapeuticsMD Inc. Markit
Nov-29-17 04:30PM  TherapeuticsMD Announces Resubmission of New Drug Application for TX-004HR Business Wire
TherapeuticsMD, Inc. operates as a women's health care product company. Its pipeline of hormone therapy drug candidates include TX-001HR, a combination of estradiol and progesterone drug candidate under clinical trials for the treatment of moderate to severe vasomotor symptoms due to menopause; TX-002HR, a natural progesterone formulation for the treatment of secondary amenorrhea without the potentially allergenic component of peanut oil; and TX-004HR, an applicator-free vaginal estradiol softgel drug candidate for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy in post-menopausal women with vaginal linings that do not receive enough estrogen. The company also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaMedMD and BocaGreenMD brands. It markets its products primarily through a direct national sales force to health care providers in the OB/GYN market space. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Finizio Robert GCEODec 20Option Exercise0.1092,9109,45818,459,469Dec 21 08:02 PM
Finizio Robert GCEODec 20Sale3.6392,910336,89218,366,559Dec 21 08:02 PM
Finizio Robert GCEODec 19Option Exercise0.1092,0009,36618,458,559Dec 21 08:02 PM
Finizio Robert GCEODec 19Sale3.7092,000340,21618,366,559Dec 21 08:02 PM
Milligan John C.K. IVPresident/SecretaryDec 18Option Exercise0.10129,12713,1451,601,546Dec 19 08:01 PM
Milligan John C.K. IVPresident/SecretaryDec 18Sale3.64129,127469,6351,472,419Dec 19 08:01 PM
Milligan John C.K. IVPresident/SecretaryDec 17Option Exercise0.10129,00013,1321,601,419Dec 19 08:01 PM
Milligan John C.K. IVPresident/SecretaryDec 17Sale3.75129,000483,7501,472,419Dec 19 08:01 PM
Bernick BrianDirectorDec 13Option Exercise0.1091,9109,3566,649,281Dec 14 08:01 PM
Bernick BrianDirectorDec 13Sale4.1291,910378,5776,557,371Dec 14 08:01 PM
Bernick BrianDirectorDec 12Option Exercise0.1091,4009,3056,648,771Dec 14 08:01 PM
Bernick BrianDirectorDec 12Sale4.1891,400381,9616,557,371Dec 14 08:01 PM
Finizio Robert GCEODec 07Option Exercise0.1092,0009,36618,458,559Dec 10 08:03 PM
Finizio Robert GCEODec 07Sale4.6092,000423,56818,366,559Dec 10 08:03 PM
Cartwright Daniel ACFODec 06Option Exercise0.3840,00015,20040,000Dec 10 08:02 PM
Finizio Robert GCEODec 06Option Exercise0.1092,0009,36618,458,559Dec 10 08:03 PM
Milligan John C.K. IVPresident/SecretaryDec 06Option Exercise0.10129,00013,1321,601,419Dec 06 08:01 PM
Milligan John C.K. IVPresident/SecretaryDec 06Sale4.57129,000589,5301,472,419Dec 06 08:01 PM
Finizio Robert GCEODec 06Sale4.5792,000420,62418,366,559Dec 10 08:03 PM
Cartwright Daniel ACFODec 06Sale4.5740,000182,80040,000Dec 10 08:02 PM
Milligan John C.K. IVPresident/SecretaryDec 04Option Exercise0.10129,00013,1321,601,419Dec 06 08:01 PM
Milligan John C.K. IVPresident/SecretaryDec 04Sale4.98129,000642,1621,472,419Dec 06 08:01 PM
Bernick BrianDirectorDec 03Option Exercise0.1091,4009,3056,648,771Dec 04 08:09 PM
Bernick BrianDirectorDec 03Sale5.1891,400473,4526,557,371Dec 04 08:09 PM
Bernick BrianDirectorNov 30Option Exercise0.1091,4009,3056,648,771Dec 04 08:09 PM
Bernick BrianDirectorNov 30Sale4.9691,400453,3446,557,371Dec 04 08:09 PM
Milligan John C.K. IVPresident/SecretaryNov 29Option Exercise0.10129,12813,1451,601,547Nov 30 08:01 PM
Milligan John C.K. IVPresident/SecretaryNov 29Sale5.03129,128650,0301,472,419Nov 30 08:01 PM
Milligan John C.K. IVPresident/SecretaryNov 28Option Exercise0.10129,00013,1321,601,419Nov 30 08:01 PM
Milligan John C.K. IVPresident/SecretaryNov 28Sale4.89129,000630,2941,472,419Nov 30 08:01 PM
Finizio Robert GCEONov 27Option Exercise0.1092,0009,36618,485,559Nov 28 08:01 PM
Finizio Robert GCEONov 27Sale4.8192,000442,06018,393,559Nov 28 08:01 PM
Finizio Robert GCEONov 26Option Exercise0.1092,0009,36618,485,559Nov 28 08:01 PM
Finizio Robert GCEONov 26Sale4.8692,000447,02818,393,559Nov 28 08:01 PM
Bernick BrianDirectorNov 20Option Exercise0.1091,4009,3056,648,771Nov 21 07:01 PM
Bernick BrianDirectorNov 20Sale4.7491,400432,8706,557,371Nov 21 07:01 PM
Bernick BrianDirectorNov 19Option Exercise0.1091,4009,3056,648,771Nov 21 07:01 PM
Bernick BrianDirectorNov 19Sale4.7591,400433,8766,557,371Nov 21 07:01 PM
Milligan John C.K. IVPresident/SecretaryNov 15Option Exercise0.10129,00013,1321,601,419Nov 16 08:02 PM
Milligan John C.K. IVPresident/SecretaryNov 15Sale4.99129,000643,5811,472,419Nov 16 08:02 PM
Milligan John C.K. IVPresident/SecretaryNov 14Option Exercise0.10129,00013,1321,601,419Nov 16 08:02 PM
Milligan John C.K. IVPresident/SecretaryNov 14Sale4.82129,000621,6511,472,419Nov 16 08:02 PM
Finizio Robert GCEONov 13Option Exercise0.1092,0009,36618,485,559Nov 14 08:02 PM
Finizio Robert GCEONov 13Sale4.8192,000442,42818,393,559Nov 14 08:02 PM
Finizio Robert GCEONov 12Option Exercise0.1092,0009,36618,485,559Nov 14 08:02 PM
Finizio Robert GCEONov 12Sale4.7392,000435,16018,393,559Nov 14 08:02 PM
Bernick BrianDirectorNov 09Option Exercise0.1091,4009,3056,648,771Nov 13 08:01 PM
Bernick BrianDirectorNov 09Sale4.8391,400441,0966,557,371Nov 13 08:01 PM
Bernick BrianDirectorNov 08Option Exercise0.1091,4009,3056,648,771Nov 13 08:01 PM
Bernick BrianDirectorNov 08Sale4.9391,400450,2366,557,371Nov 13 08:01 PM
Cartwright Daniel ACFONov 07Option Exercise0.3840,00015,20040,000Nov 13 07:35 AM
Cartwright Daniel ACFONov 07Sale4.8540,000194,0000Nov 13 07:35 AM
Finizio Robert GCEOOct 26Option Exercise0.1092,0009,36618,485,559Oct 29 09:00 PM
Finizio Robert GCEOOct 26Sale5.1292,000470,76418,393,559Oct 29 09:00 PM
Finizio Robert GCEOOct 25Option Exercise0.1092,0009,36618,485,559Oct 29 09:00 PM
Finizio Robert GCEOOct 25Sale5.4592,000501,30818,393,559Oct 29 09:00 PM
Milligan John C.K. IVPresident/SecretaryOct 24Option Exercise0.10125,00012,7251,597,419Oct 25 09:06 PM
Milligan John C.K. IVPresident/SecretaryOct 24Sale5.37125,000671,2501,472,419Oct 25 09:06 PM
Milligan John C.K. IVPresident/SecretaryOct 23Option Exercise0.10125,00012,7251,597,419Oct 25 09:06 PM
Milligan John C.K. IVPresident/SecretaryOct 23Sale5.33125,000666,2501,472,419Oct 25 09:06 PM
Bernick BrianDirectorOct 19Option Exercise0.1091,4009,3056,648,771Oct 22 07:19 PM
Bernick BrianDirectorOct 19Sale5.5191,400503,6146,557,371Oct 22 07:19 PM
Bernick BrianDirectorOct 18Option Exercise0.1091,4009,3056,648,771Oct 22 07:19 PM
Bernick BrianDirectorOct 18Sale5.6191,400512,7546,557,371Oct 22 07:19 PM
Finizio Robert GCEOOct 12Option Exercise0.1092,0009,36618,485,559Oct 15 07:01 PM
Finizio Robert GCEOOct 12Sale5.4592,000501,21618,393,559Oct 15 07:01 PM
Finizio Robert GCEOOct 11Option Exercise0.1092,0009,36618,485,559Oct 15 07:01 PM
Finizio Robert GCEOOct 11Sale5.6592,000519,61618,393,559Oct 15 07:01 PM
Milligan John C.K. IVPresident/SecretaryOct 10Option Exercise0.10125,00012,7251,597,419Oct 11 07:01 PM
Milligan John C.K. IVPresident/SecretaryOct 10Sale5.76125,000719,6251,472,419Oct 11 07:01 PM
Milligan John C.K. IVPresident/SecretaryOct 09Option Exercise0.10125,00012,7251,597,419Oct 11 07:01 PM
Milligan John C.K. IVPresident/SecretaryOct 09Sale5.95125,000743,1251,472,419Oct 11 07:01 PM
Bernick BrianDirectorOct 05Option Exercise0.1091,4009,3056,648,771Oct 09 07:00 PM
Bernick BrianDirectorOct 05Sale5.9391,400542,0026,557,371Oct 09 07:00 PM
Bernick BrianDirectorOct 04Option Exercise0.1091,4009,3056,648,771Oct 09 07:00 PM
Bernick BrianDirectorOct 04Sale5.8991,400538,3466,557,371Oct 09 07:00 PM
Bernick BrianDirectorSep 28Option Exercise0.1091,4009,3056,648,771Oct 01 07:01 PM
Bernick BrianDirectorSep 28Sale6.5591,400598,5796,557,371Oct 01 07:01 PM
Bernick BrianDirectorSep 27Option Exercise0.1091,4009,3056,648,771Oct 01 07:01 PM
Bernick BrianDirectorSep 27Sale6.6391,400605,9826,557,371Oct 01 07:01 PM
Milligan John C.K. IVPresident/SecretarySep 26Option Exercise0.10125,00012,7251,597,419Sep 27 07:02 PM
Milligan John C.K. IVPresident/SecretarySep 26Sale6.78125,000847,0001,472,419Sep 27 07:02 PM
Milligan John C.K. IVPresident/SecretarySep 25Option Exercise0.10125,00012,7251,597,419Sep 27 07:02 PM
Milligan John C.K. IVPresident/SecretarySep 25Sale6.78125,000847,2501,472,419Sep 27 07:02 PM
Finizio Robert GCEOSep 21Option Exercise0.1092,0009,36618,485,559Sep 24 07:01 PM
Finizio Robert GCEOSep 21Sale6.6792,000613,64018,393,559Sep 24 07:01 PM
Finizio Robert GCEOSep 20Option Exercise0.1092,0009,36618,485,559Sep 24 07:01 PM
Finizio Robert GCEOSep 20Sale6.5892,000605,36018,393,559Sep 24 07:01 PM
Bernick BrianDirectorSep 13Option Exercise0.1091,4009,3056,648,771Sep 14 07:34 PM
Bernick BrianDirectorSep 13Sale6.3591,400579,9336,557,371Sep 14 07:34 PM
Bernick BrianDirectorSep 12Option Exercise0.1091,4009,3056,648,771Sep 14 07:34 PM
Bernick BrianDirectorSep 12Sale6.2691,400571,7076,557,371Sep 14 07:34 PM
Milligan John C.K. IVPresident/SecretarySep 11Option Exercise0.10125,00012,7251,597,419Sep 12 08:19 PM
Milligan John C.K. IVPresident/SecretarySep 11Sale6.13125,000765,7501,472,419Sep 12 08:19 PM
Milligan John C.K. IVPresident/SecretarySep 10Option Exercise0.10125,00012,7251,597,419Sep 12 08:19 PM
Milligan John C.K. IVPresident/SecretarySep 10Sale6.07125,000758,1251,472,419Sep 12 08:19 PM
Finizio Robert GCEOSep 07Option Exercise0.1092,0009,36618,485,559Sep 10 07:00 PM
Finizio Robert GCEOSep 07Sale6.2292,000572,24018,393,559Sep 10 07:00 PM
Finizio Robert GCEOSep 06Option Exercise0.1092,0009,36618,485,559Sep 10 07:00 PM
Finizio Robert GCEOSep 06Sale6.2592,000575,00018,393,559Sep 10 07:00 PM